Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer

Familial Cancer

Volumn 7, Issue 4, 2008, Pages 347-359

  De Leeuw, J R J ^a   Van Vliet, M J ^a   Ausems, M G E M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

BRCA carrier; Breast cancer; Ovarian cancer; Predictors; Prophylactic surgery; Surveillance

Indexed keywords

ANXIETY; ARTICLE; BREAST CANCER; BREAST SELF EXAMINATION; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CLINICAL EXAMINATION; DEMOGRAPHY; EDUCATIONAL STATUS; HUMAN; MASTECTOMY; OUTCOME ASSESSMENT; OVARY CANCER; PREDICTOR VARIABLE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOLOGICAL ASPECT; SALPINGOOOPHORECTOMY; SYSTEMATIC REVIEW;

BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; OVARIAN NEOPLASMS; PATIENT COMPLIANCE; SOCIOECONOMIC FACTORS;

EID: 55949101099     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-008-9189-5     Document Type: Article

References (59)

1. MR Andersen D Bowen Y Yasui A McTiernan 2003 Awareness and concern about ovarian cancer among women at risk because of a family history of breast or ovarian cancer Am J Obstet Gynecol 189 42 47
2. MR Andersen S Peacock J Nelson S Wilson M McIntosh C Drescher 2002 Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer Gynecol Oncol 85 3 8
3. MR Andersen R Smith H Meischke D Bowen N Urban 2003 Breast cancer worry and mammography use by women with and without a family history in a population-based sample Cancer Epidemiol Biomarkers Prev 12 314 320
4. Y Antill JC Reynolds MA Young J Kirk K Tucker T Bogtstra 2006 Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer Eur J Cancer 42 621 628
5. A Antoniou PD Pharoah S Narod HA Risch JE Eyfjord JL Hopper 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 1117 1130
6. PI Borgen AD Hill KN Tran KJ Van Zee MJ Massie D Payne 1998 Patient regrets after bilateral prophylactic mastectomy Ann Surg Oncol 5 603 606
7. JR Botkin KR Smith RT Croyle BJ Baty JE Wylie D Dutson 2003 Genetic testing for a BRCA1 mutation, prophylactic surgery and screening behavior in women 2 years post testing Am J Med Genet 118A 201 209
8. L Bouchard I Blancquaert F Eisinger WD Foulkes G Evans H Sobol 2004 Prevention and genetic testing for breast cancer: variations in medical decisions Soc Sci Med 58 1085 1096
9. K Brain P Norman J Gray R Mansel 1999 Anxiety and adherence to breast self-examination in women with a family history of breast cancer Psychosom Med 61 181 187
10. W Burke M Daly J Garber J Botkin MJ Kahn P Lynch 1997 Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2 Cancer Genetics Studies Consortium JAMA 277 997 1003
11. D Cella C Hughes A Peterman C Chang BN Peshkin MD Schwartz 2002 A brief assessment of concerns associated with genetic testing for cancer, the Multidimensional Impact of Cancer Risk Assessment (MICRA) Questionnaire Health Psychol 21 564 572
12. MB Daly CL Lerman E Ross MD Schwartz CB Sands A Masny 1996 Gail model breast cancer risk components are poor predictors of risk perception and screening behavior Breast Cancer Res Treat 41 59 70
13. F De Waard HJ Collette JJ Rombach EA Baanders-van Halewijn C Honing 1984 The DOM project for the early detection of breast cancer, Utrecht, The Netherlands J Chronic Dis 37 1 44
14. MA Diefenbach SM Miller MB Daly 1999 Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer Health Psychol 18 532 536
15. A Eisen TR Rebbeck WC Wood BL Weber 2000 Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer J Clin Oncol 18 1980 1995
16. SA Epstein TH Lin J Audrain M Stefanek B Rimer C Lerman 1997 Excessive breast self-examination among first-degree relatives of newly diagnosed breast cancer patients. High-risk breast cancer consortium Psychosomatics 38 253 261
17. J Erblich D Bovbjerg B Heiddis H Valdimarsdottir 2000 Psychological distress, health beliefs, and frequency of breast self-examination J Behav Med 23 277 292
18. DG Evans E Anderson F Lalloo HF Vasen M Beckman D Eccles 1999 Utilization of prophylactic mastectomy in 10 European centres Dis Markers 15 148 151
19. D Evans F Lalloo P Hopwood A Maurice A Baildam A Brain 2005 Surgical decisions made by 158 women with hereditary breast cancer aged <50 years Eur J Surg Oncol 31 1112 1118
20. BJ Hailey CL Carter DR Burnett 2000 Breast cancer attitudes, knowledge, and screening behavior in women with and without a family history of breast cancer Health Care Women Int 21 701 715
21. J Hay KD McCaul R Magnan 2006 Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence Prev Med 42 401 408
22. C Isaacs BN Peshkin M Schwartz TA DeMarco D Main C Lerman 2002 Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer Breast Cancer Res Treat 71 103 112
23. CM Julian-Reynier LJ Bouchard DG Evans FA Eisinger WD Foulkes B Kerr 2001 Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women Cancer 92 959 968
24. KM Kash JC Holland MS Halper DG Miller 1992 Psychological distress and surveillance behaviors of women with a family history of breast cancer J Natl Cancer Inst 84 24 30
25. ES King N Resch B Rimer C Lerman A Boyce P McGovern-Gorchov 1993 Breast cancer screening practices among retirement community women Prev Med 22 1 19
26. AY Kinney G Emery WN Dudley RT Croyle 2002 Screening behaviors among African American women at high risk for breast cancer: do beliefs about God matter? Oncol Nurs Forum 29 835 843
27. C Lerman M Daly C Sands A Balshem E Lustbader T Heggan 1993 Mammography adherence and psychological distress among women at risk for breast cancer J Natl Cancer Inst 85 1074 1080
28. C Lerman C Hughes RT Croyle D Main C Durham C Snyder 2000 Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing Prev Med 31 75 80
29. Lerman C, Kash K, Stefanek M (1994) Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr:171-176
30. C Lerman M Schwartz 1993 Adherence and psychological adjustment among women at high risk for breast cancer Breast Cancer Res Treat 28 145 155
31. Lux m S Ackermann M Bani C Nestle-Kramling T Goecke D Niederacher 2005 Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancer Eur J Cancer Prev 14 503 511
32. Lux m S Ackermann C Nestle-Kramling T Goecke D Niederacher R Bodden-heidrich 2005 Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancer Eur J Cancer Prev 14 399 411
33. HT Lynch C Snyder J Lynch P Karatoprakli A Trowonou K Metcalfe 2006 Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families Can Genet Cytogen 165 91 97
34. KD McCaul AD Branstetter SM O'Donnell K Jacobson KB Quinlan 1998 A descriptive study of breast cancer worry J Behav Med 21 565 579
35. PA Meeuwissen C Seynaeve CT Brekelmans HJ Meijers-Heijboer JG Klijn CW Burger 2005 Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer Gynecol Oncol 97 476 482
36. EJ Meijers-Heijboer LC Verhoog CT Brekelmans C Seynaeve MM Tilanus-Linthorst A Wagner 2000 Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation Lancet 355 2015 2020
37. H Meijers-Heijboer B van-Geel WLJ van-Putten SC Henzen-Logmans C Seynaeve MBE Menke-Pluymers 2001 Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 345 159 164
38. B Meiser P Butow A Barratt M Friedlander M Gattas J Kirk 1999 Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer Gynecol Oncol 75 122 129
39. B Meiser P Butow A Barratt M Friedlander J Kirk C Gaff 2000 Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer Breast Cancer Res Treat 59 101 111
40. B Meiser PN Butow AL Barratt V Schnieden M Gattas J Kirk 2001 Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer Patient Educ Couns 44 215 225
41. B Meiser K Tiller MA Gleeson L Andrews G Robertson KM Tucker 2000 Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer Psychooncology 9 496 503
42. SA Narod K Offit 2005 Prevention and management of hereditary breast cancer J Clin Oncol 23 1656 1663
43. C Neise M Rauchfuss S Paepke K Beier W Lichtenegger 2001 Risk perception and psychological strain in women with a family history of breast cancer Onkologie 24 470 475
44. Oei 2006 Surveillance of women at high risk for hereditary ovarian cancer is inefficient Br J Cancer 94 814 819
45. DK Payne C Biggs KN Tran PI Borgen MJ Massie 2000 Women's regrets after bilateral prophylactic mastectomy Ann Surg Oncol 7 150 154
46. BN Peshkin MD Schwartz C Isaacs C Hughes D Main C Lerman 2002 Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing Cancer Epidemiol Biomarkers Prev 11 1115 1118
47. AH Pieterse MG Ausems AM Van Dulmen FA Beemer JM Bensing 2005 Initial cancer genetic counseling consultation, change in counselees' cognitions and anxiety, and association with addressing their needs and preferences Am J Med Genet 137 27 35
48. RW Sattin GL Rubin LA Webster CM Huezo PA Wingo HW Ory 1985 Family history and the risk of breast cancer JAMA 253 1908 1913
49. L Scheuer N Kauff M Robson B Kelly R Barakat J Satagopan 2002 Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers J Clin Oncol 20 1260 1268
50. MD Schwartz E Kaufman BN Peshkin C Isaacs C Hughes T Demarco 2003 Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing J Clin Oncol 21 4034 4041
51. MD Schwartz C Lerman B Brogan BN Peshkin CH Halbert T Demarco 2004 Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients J Clin Oncol 22 1823 1829
52. M Schwartz C Lerman M Daly J Audrain A Masny K Griffith 1995 Utilization of ovarian cancer screening by women at increased risk Cancer Epidemiol Biomarkers Prev 4 269 273
53. MD Schwartz BN Peshkin C Hughes D Main C Isaacs C Lerman 2002 Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample J Clin Oncol 20 514 520
54. ML Slattery RA Kerber 1993 A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database JAMA 270 1563 1568
55. ME Stefanek KJ Helzlsouer PM Wilcox F Houn 1995 Predictors of and satisfaction with bilateral prophylactic mastectomy Prev Med 24 412 419
56. KP Tercyak C Lerman BN Peshkin C Hughes D Main C Isaacs 2001 Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk Health Psychol 20 217 222
57. K Tiller B Meiser P Butow M Clifton B Thewes M Friedlander 2002 Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study Gynecol Oncol 86 212 219
58. ST Tinley J Houfek P Watson L Wenzel MB Clark S Coughlin 2004 Screening adherence in BRCA1/2 families is associated with primary physicians' behavior Am J Med Genet 125A 5 11
59. S Van Dooren A Rijnsburger C Seynaeve A Kriege H Duivenvoorden C Bartels 2003 Psychological distress and breast self examination frequency in women at increased risk for hereditary or familial breast cancer Commun Genet 6 235 241